兔抗MET多克隆抗體

Background:

The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene.

Applications:

ELISA, WB, IHC

Name of antibody:

MET

Immunogen:

Synthetic peptide of human MET

Full name:

MET proto-oncogene, receptor tyrosine kinase

Synonyms:

HGFR; AUTS9; RCCP2; c-Met; DFNB97

SwissProt:

P08581

IHC positive control:

Human esophagus cancer

IHC Recommend dilution:

25-100

WB Predicted band size:

156 kDa

WB Positive control:

Hela and A431 cell lysates

WB Recommended dilution:

500-2000